Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ram Ron
24 years of experience
Clinic is certified :
Hematology oncology treatment in Israel typically costs between $2,200 and $240,000. Prices vary based on the specific diagnosis, the complexity of the treatment protocol, and whether the facility is public or private. International patients often find savings of 30-80% compared to the United States for advanced procedures.
Typical Hematology Oncology Costs in Israel
Major medical centers located in Tel Aviv, Ramat Gan, and Jerusalem lead the field in specialized oncology care. While treatment costs are generally consistent across these hubs, private centers in Tel Aviv might differ in pricing structure. Consult with a specialist to get accurate pricing for your specific medical needs.
| Israel | Turkey | Austria | |
| Plasmapheresis | from $2,200 | from $1,200 | from $2,000 |
| Lymphoma chemotherapy | from $24,000 | from $3,000 | from $8,000 |
| Chemotherapy | from $2,400 | from $2,430 | from $2,500 |
| CAR T-cell therapy | from $72,000 | from $150,000 | from $350,000 |
| Bone marrow transplantation | from $135,000 | from $36,000 | from $140,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Hematology Oncology treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hematology Oncology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hematology Oncology treatment journey.
Head of Hematology at Sourasky Medical Center – Israel's premier hospital for blood cancer care.
Several hundred stem cell transplants performed – Dr. Ram specializes in complex hematologic cases at Sourasky Medical Center.
300+ pediatric bone marrow and umbilical blood transplants – Dr. El Hasid leads the Pediatric Oncohematology Department at Dana Dwek Children's Hospital.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Written by Anna Leonova
Written by Anna Leonova
Written by Halina Shubala